With the onset of the pandemic, CHIL rapidly initiated the in-house production and export of its first antibody tests.
This step contributed to maintaining supply continuity during a period of severe global shortage.
In February 2019, CHIL participated in Medlab Middle East, Dubai.
In November 2019, CHIL participated in MEDICA Messe Düsseldorf, Düsseldorf.